Childress Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.8M Sell
3,044
-1,043
-26% -$1.06M 0.5% 35
2025
Q4
$4.39M Buy
4,087
+819
+25% +$783K 0.7% 30
2025
Q3
$2.49M Buy
3,268
+634
+24% +$472K 0.46% 41
2025
Q2
$2.05M Buy
2,634
+141
+6% +$110K 0.52% 36
2025
Q1
$2.06M Buy
2,493
+79
+3% +$65.7K 0.6% 31
2024
Q4
$1.86M Sell
2,414
-31
-1% -$25.7K 0.52% 35
2024
Q3
$2.17M Buy
2,445
+105
+4% +$94.4K 0.58% 32
2024
Q2
$2.12M Buy
2,340
+60
+3% +$48K 0.6% 31
2024
Q1
$1.77M Sell
2,280
-208
-8% -$148K 0.52% 38
2023
Q4
$1.45M Sell
2,488
-23
-0.9% -$13.4K 0.43% 43
2023
Q3
$1.35M Buy
2,511
+1,948
+346% +$1M 0.44% 41
2023
Q2
$264K Sell
563
-511
-48% -$214K 0.11% 64
2023
Q1
$369K Sell
1,074
-1,713
-61% -$578K 0.16% 59
2022
Q4
$1.02M Buy
2,787
+62
+2% +$22K 0.34% 53
2022
Q3
$892K Sell
2,725
-118
-4% -$37.4K 0.35% 54
2022
Q2
$922K Buy
2,843
+210
+8% +$63K 0.37% 54
2022
Q1
$755K Buy
2,633
+402
+18% +$103K 0.26% 70
2021
Q4
$616K Buy
2,231
+57
+3% +$14.4K 0.25% 74
2021
Q3
$502K Buy
2,174
+113
+5% +$27.9K 0.2% 93
2021
Q2
$473K Buy
2,061
+340
+20% +$68.3K 0.22% 80
2021
Q1
$321K Buy
1,721
+1,048
+156% +$205K 0.15% 122
2020
Q4
$116K Buy
+673
New +$100K 0.07% 135

Other funds holding LLY

Childress Capital Advisors's LLY Position: Q1 2026 in Review

Childress Capital Advisors reduced its Eli Lilly (LLY) stake by 26% in Q1 2026, selling an estimated $1.06M and leaving 3,044 shares worth $2.8M. The position accounts for 0.5% of the portfolio, ranked #35.

Childress Capital Advisors first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.39M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Childress Capital Advisors held 3,044 shares of Eli Lilly worth $2.8M as of Q1 2026.
  • Childress Capital Advisors sold 1,043 Eli Lilly shares in Q1 2026, an estimated $1.06M.
  • Eli Lilly made up 0.5% of Childress Capital Advisors's portfolio in Q1 2026, its #35 holding.
  • Childress Capital Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Childress Capital Advisors's Eli Lilly position peaked at $4.39M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Childress Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.